Science keeps winning! Scientists recently transplanted a pig’s kidney into a human being without immediate rejection by the immune system.
A step in the right direction, the achievement could help ease the shortage of human organs for transplant by using animal organs.
Performed at the NYU Langone Health in New York City, the procedure used the kidney of a pig whose genes had been modified to get rid of a particular molecule which causes human immune systems to reject animal organs.
According to Reuters, the recipient of the pig kidney is a comatose patient who was experiencing kidney dysfunction. The subject’s family consented to the pig kidney transplantation before she was set to be taken off life support.
How was the procedure done?
In the pilot phase of the transplant, the pig kidney was attached to her blood vessels but kept outside the body. This gave researchers access to the kidney for three days in case things were to go awry.
The kidney function after the transplant appears to be normal so far. Turns out the kidney is also making as much urine as expected from a kidney. In fact, Dr. Robert Montgomery, the lead researcher of the study told Reuters that it’s working akin to a human kidney.
The most telling sign of the pig kidney working? The recipient’s kidney function has become normal again. Earlier, the subject’s creatinine levels were abnormal and now they appear stable.
Kidney shortage in India
Researchers across the globe have been working for decades to transplant animal kidneys into humans. Unfortunately, the immediate rejection has remained extremely high among recipients. With this new pig kidney transplant, things may be headed for a shake-up.
According to Narayana Health, almost 200,000 patients in India are awaiting organ donation with only 15,000 available donors. This gap could be filled with animal transplants modelled around this one.
Reference:
https://www.indiatimes.com/technology/science-and-future/pig-kidney-transplant-in-human-552148.html
Donald Trump’s tariffs of 50% have come into force on most US imports from India. India’s giant generic pharmaceuticals sector and its electronics and petroleum products are exempt from the tariffs. Aluminium, steel and copper remain at 25%, but job-heavy sectors such as textiles, jewellery, seafood and leather are squarely in the line of fire.
The European Chemicals Agency (ECHA) has published the updated proposal to restrict per- and polyfluoroalkyl substances (PFAS) under the EU’s chemicals regulation, REACH. The update has been prepared by the authorities from Denmark, Germany, the Netherlands, Norway and Sweden, who submitted the initial proposal in January 2023.
Most chemicals exported from the 27 member countries of the European Union into the US will be subject to a 15% tariff on top of their selling prices under an agreement signed on July 27 between the US and the European Commission.
We’re thrilled to announce a new strategic alliance between ExSyn, Exim-Indis and simABs, a leading EU-based biologics manufacturer known for its patented continuous flow technology in antibody production.
The global trade landscape is undergoing significant changes following the announcement of new reciprocal tariffs by the United States government. Recent developments indicate significant shifts in global trade dynamics, with key policy adjustments, ongoing negotiations, and evolving logistics patterns. Below is a summary of the latest developments.
In January 2025, the US FDA published a draft regulatory guidance entitled “The Considerations for Use of Artificial Intelligence to Support Regulatory Decision-Making for Drug and Biological Products”.
The adoption of artificial intelligence (AI) and large language models (LLMs) is rapidly reshaping clinical research and drug development.
In the quest for increased sustainability, a lot has been made of the potential to use bio-based raw materials, captured CO2 and recycled plastics as raw materials for new chemicals. But what about using biotech processes to manufacture chemicals? Could it offer a more sustainable alternative to traditional petrochemical processing, and be more amenable to biobased raw materials?
High duties on imports from Canada, Mexico and China raise problems for international supply chains.